Management of Microcytic Anemia with Restless Legs in a 15-Year-Old
This adolescent has iron deficiency anemia (microcytic, hypochromic) causing restless legs syndrome and requires immediate iron repletion—preferably intravenous ferric carboxymaltose 1000 mg or oral ferrous sulfate 325-650 mg daily. 1
Diagnostic Interpretation
The laboratory findings indicate iron deficiency anemia:
- RBC 5.53 ×10^12/L is elevated (compensatory erythrocytosis) 2
- MCV 78 fL confirms microcytosis (normal adolescent range >80 fL) 3
- MCH 24.4 pg confirms hypochromia (reduced hemoglobin per cell) 4
This pattern—elevated RBC count with low MCV and MCH—is pathognomonic for iron deficiency, where the bone marrow produces more cells but each cell is smaller and contains less hemoglobin. 2
Iron Status Assessment Required
Immediately measure serum ferritin and transferrin saturation to confirm iron deficiency and guide treatment intensity. 1, 5
- If ferritin ≤100 ng/mL or transferrin saturation <20%, iron repletion is mandatory for both the anemia and RLS symptoms 6, 1
- These thresholds are higher than traditional anemia cutoffs because RLS requires adequate brain iron stores, not just systemic sufficiency 5
Iron Repletion Strategy
First-Line: Intravenous Iron (Preferred)
Intravenous ferric carboxymaltose 1000 mg receives a strong recommendation from the 2025 American Academy of Sleep Medicine guidelines for RLS patients with low iron stores. 6, 1
- IV iron provides rapid, complete repletion without gastrointestinal side effects 6
- Alternative IV formulations include ferumoxytol or low molecular weight iron dextran (conditional recommendations) 6
Alternative: Oral Iron
Ferrous sulfate 325-650 mg daily (or every other day) is conditionally recommended if IV access is problematic. 6, 1
- Oral iron is effective but slower, with common side effects including constipation that may lead to discontinuation 6
- Every-other-day dosing may improve tolerability while maintaining efficacy 1
- In pediatric RLS studies, oral iron supplementation demonstrated ferritin-concentration-dependent clinical improvement 7
Restless Legs Syndrome Management
Medication Review
Discontinue any medications that exacerbate RLS, including: 6, 1
- Serotonergic antidepressants 5
- Dopamine antagonists (antiemetics, antipsychotics) 5
- Centrally acting H1 antihistamines (diphenhydramine) 5
Lifestyle Modifications
Address exacerbating factors: 6
- Eliminate caffeine and alcohol 6
- Ensure adequate sleep hygiene 6
- Screen for obstructive sleep apnea if clinically indicated 6
Pharmacologic Therapy (If Iron Repletion Insufficient)
If RLS symptoms persist after iron repletion, initiate a gabapentinoid (gabapentin, gabapentin enacarbil, or pregabalin)—all carry strong recommendations as first-line agents. 6, 1
- Approximately 70% of patients achieve much or very much improved symptoms with gabapentinoids versus 40% with placebo 5
- Avoid dopamine agonists (pramipexole, ropinirole, rotigotine) as first-line therapy due to 7-10% annual risk of augmentation (iatrogenic worsening of RLS) 1, 5
Critical Pitfalls to Avoid
Do not use topical therapies (magnesium or capsaicin creams)—the 2025 AASM guidelines explicitly recommend against them because systemic absorption and central nervous system effects are required for RLS treatment. 1
Do not overlook the iron-RLS connection: Even with "normal" systemic iron studies, brain iron deficiency may persist and drive RLS symptoms, which is why the ferritin threshold of ≤100 ng/mL (not the traditional <15 ng/mL for anemia) is used. 5
Monitor for constipation with oral iron in adolescents, as this is the most common reason for treatment discontinuation. 6
Expected Clinical Course
RLS symptoms in children as young as 7.5 months have been documented to improve with iron supplementation, with relief correlating directly with rising ferritin levels. 7 In this 15-year-old, expect gradual improvement in both anemia parameters and restless legs symptoms over 4-12 weeks with oral iron, or more rapidly (within weeks) with IV iron. 6, 7